Some key drugs are gonadotropins, anti-estrogens, and aromatase inhibitors. Infertility refers to the inability to conceive after one year of unprotected intercourse. It can be caused due to various factors like hormonal imbalance, genetic issues, anatomical problems, age-related factors, infections, environmental factors, etc. According to the World Health Organization (WHO), around 48.5 million couples globally experience infertility. Infertility rate is steadily increasing worldwide due to rising age of motherhood, risk-prone lifestyle habits, environmental pollution, among other factors. This has augmented the demand for infertility treatment and drugs across regions.
The global infertility drugs market is estimated to be valued at US$ 4262.17 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Global Infertility Drugs Market Size are Koninklijke Philips N.V., LifeWatch USA, Tunstall, Apple Inc., ADT Security Services, Medical Guardian LLC, MobileHelp, Bay Alarm Company, MariCare Oy, Origin Wireless, The ADT Corporation, Singapore Technologies Electronics Limited, Semtech Corporation. Key players are involved in new product launches, mergers & acquisitions and geographical expansion to cement their market position.
There are various opportunities in the infertility drugs market including increasing awareness and adoption of infertility treatment in emerging economies. Many developing nations are witnessing rising disposable income levels which is positively impacting the spending on infertility treatment and drugs.
Globally, the infertility drugs market is expanding due to growing medical tourism in fertility treatment. Countries like India, Mexico, Thailand, and Turkey are attracting large number of international patients for infertility services owing to availability of advanced infrastructure and cost-effective treatment options. This trend will continue boosting the demand for infertility drugs from across the globe.
Market Drivers
Infertility cases are rapidly increasing worldwide mainly due to changing lifestyle habits including rising stress levels, erratic work schedules, smoking, obesity, substance abuse, alcohol consumption, etc. This has augmented the demand for infertility treatment significantly. Since there are limited alternate treatment options available to couples failing to conceive naturally for over a year, need of infertility drugs is anticipated to surge in the forthcoming years.
Market Restrains
However, the high cost associated with infertility treatment including drugs, procedures and assisted reproductive techniques is a major factor hampering the market growth. Additionally, infertility drugs are associated with certain health risks like ovarian hyperstimulation syndrome (OHSS), birth defects in babies, etc. which discourages some patients. Stringent regulatory environment concerning fertility drugs is also a challenge faced by manufacturers.
Segment Analysis
The Infertility Drugs market dominating sub segment is assisted reproductive technology (ART) which includes drugs for In-Vitro Fertilization, Intrauterine Insemination, Intracervical Insemination, and Intracytoplasmic sperm injection. ART involve complex medical procedures and are often costly, hence they tend to be more preferred by patients with a higher income. Procedures like IVF contribute to over 50% of the overall infertility drugs market owing to higher success rate compared to other options.
Global Analysis:
North America has been the largest market for infertility drugs and is expected to be the fastest growing region during the forecast period. This is mainly due to the increasing incidence of infertility, rising awareness about treatment options, availability of advanced fertility clinics and rising focus of key players on developing advanced technologies. Within North America, United States dominates due to high awareness levels, easy availability of fertility treatments and rising number of fertility clinics. Europe holds the second position in terms of market share due to growing demand from countries like Germany, UK and France and rising investments in research for developing advanced treatment options. The Asia Pacific is expected to emerge as the most promising region during the forecast period due to growing medical tourism, rising access to advanced fertility treatments and increasing initiatives by leading players. Countries like India, China and Japan will witness rapid growth due to significant patient population and improving healthcare infrastructure.
Get More Insights On This Topic: https://www.ukwebwire.com/infertility-drugs-market-size-share-analysis-2023-2030-2/
Comments
0 comment